Background: Mast cells serve an important sentinel function at mucosal barriers
| INTRODUCTION
Food allergy is a currently intractable disease in which affected individuals exhibit dysregulated immunological responses to normally innocuous ingested protein allergens, resulting in sensitization with the production of allergen-specific IgE antibodies. In its most severe form, the resultant IgE-mediated hypersensitivity activated upon subsequent food ingestion can result in life-threatening anaphylactic shock, and food allergy is thus responsible for a substantial fraction of emergency hospital visits. [1] [2] [3] [4] Incidence of the disease has risen dramatically in the last couple of decades, and current estimates suggest that around 6-8% of children are sensitized to one or more foods in westernized nations. 5 A recent study in JAMA Pediatrics calculated the economic burden of food allergy at around $25 billion a year, most of which is due to indirect costs and changes in lifestyle rather than direct medical care. 6 The need for constant vigilance against allergen exposure in the course of everyday life along with the ever-present fear of reaction is sources of significant anxiety. 7 The factors predisposing some individuals to the development of anaphylactic sensitivity to food allergens have not been fully elucidated. It is known that mast cells and basophils promote the induction of pro-allergic adaptive immune responses by providing cytokines, including IL-4 and IL-9, that drive Th2 expansion and inhibit the generation of regulatory T (Treg) cells in the intestinal mucosa. [8] [9] [10] [11] This immunological environment is conducive to the production of foodspecific IgE antibodies that then bind to tissue mast cells via the highaffinity IgE receptor, FceRI, and lead to activation following re-exposure to allergens. Activated mast cells release preformed and newly synthesized vasoactive amines and lipid mediators that act on vascular endothelium and a number of other target tissues to cause anaphylaxis. 12 Although the presence of food-specific IgE antibodies is required to trigger this reaction, there is a poor correlation between IgE levels and severity of anaphylaxis. For instance, some individuals testing positive for IgE will pass oral food challenges while others with similar IgE levels will develop severe reactions. 5 Id2-and Rora-dependent manner. [13] [14] [15] [16] They are identified by the absence of markers that define other leucocyte lineages combined with expression of the transcription factor GATA-3 or surface markers such as Thy1 (CD90), the IL-2 receptor CD25, the IL-7 receptor CD127, the IL-33 receptor ST2, the IL-25 receptor IL-17RB, ICOS
and Sca-1. 15 Since being described in 2010, ILC2 have been implicated in the pathology of allergic diseases as well as productive immunity against helminth parasites. [17] [18] [19] [20] [21] [22] [23] [24] [25] The exceptionally high level of IL-13 secreted by ILC2 leads to subepithelial collagen deposition and airway hyperreactivity in murine models of asthma and to worm expulsion through goblet cell hyperplasia and smooth muscle contraction in parasite-infested mice. 26 ILC2 and mast cells exhibit coordinate increases during allergic responses (eg,in the asthmatic lung and in the skin in atopic dermatitis), and both are found basally at relatively high frequencies in the lamina propria of the small intestine. 18, 20, 27 Recent studies have demonstrated that ILC2-and ILC2-associated cytokines favour allergic sensitization to foods. 24, 25, [28] [29] [30] As mast cells serve as innate mucosal sentinels for allergens and danger signals and have been shown to exhibit marked IgE-dependent up-regulation of ILC2-inducing cytokines, we hypothesized that IgE and mast cells might directly promote ILC2 accumulation.
In this report, using two models of food allergy, we found that 
| Isolation of intestinal leucocytes
Leucocytes were isolated from the jejunal lamina propria for analysis by flow cytometry and cell culture according to previously described procedures. 36, 37 The 
| Peanut sensitization
Mice were intragastrically fed with 22. CA, USA) as previously described. 8, 38 Responsiveness to mast cell mediators was assessed by injection with 1 mg of histamine or serotonin (both Sigma-Aldrich) as previously described. 36, 39 Core body temperature was monitored using subcutaneously implanted temperature transponders, and data were acquired using a DAS-6001 console (Bio Medic Data Systems, Seaford, DE, USA) as previously described. 
| ILC2 adoptive transfer
Leucocytes were isolated from the intestinal lamina propria and cultured under ILC2-expanding conditions (IL-2, IL-4, IL-33 and IL-25) for 5 days, as described above. ILC2 were then purified by flow sorting as described above and expanded in culture for an additional 3-7 days.
The cells were then washed and counted, and 2910 5 were injected i.v.
via the retro-orbital sinus of unmanipulated (unirradiated) WT BALB/c mice. Adoptive transfers were performed 16 hours prior to challenge.
| ELISAs
Sandwich ELISAs were performed using a kit for MMCP-1 (eBioscience). IL-13 was assessed using matched antibody pairs: clones eBio13A and eBio1316H from eBioscience. OVA-and peanut-specific IgE were measured by capturing IgE with 3 lg/ml goat antimouse IgE (Southern Biotech, Birmingham, AL, USA) followed by detection with 200 ng/mL biotinylated OVA or peanut extract (as appropriate) as previously described.
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| Statistical analysis
Data were plotted and analysed using Prism GraphPad (GraphPad Software, Inc., La Jolla, CA, USA) (version 5.0f). Temperature curves were analysed using repeated measures two-way ANOVA to calculate P values between groups. All other data were analysed using Mann-Whitney unpaired t tests (for two groups), ANOVA with Bonferroni post-tests (for three or more groups) or 2-way ANOVA with
Sidak's multiple comparison testing (two variables). In cases where values were spread across multiple orders of magnitude, data were log-transformed prior to analysis with parametric tests. Two-tailed P values are summarized as follows: *P < .05, **P < .01, ***P < .001
and ****P < .0001.
| RESULTS
ILC2 exacerbate allergic sensitization to foods in murine models, but the mechanisms driving their expansion remain unclear. Recent reports have demonstrated the importance of IL-25 and IL-33. 24, 25, 29, 40 While these are both generally considered to be epithelial-derived cytokines, 30 several groups have shown that they can be produced at high levels by haematopoietic cells, including mast cells. 41, 42 Furthermore, additional cytokines including IL-2, IL-4 and IL-7 stimulate ILC2 growth and cytokine production, raising the possibility that food allergen-driven ILC2 activation may not be exclusively a response to damage of the epithelial barrier. We have demonstrated that IgE, mast cells and ILC2 are all important for achieving robust Th2 responses and IgE production in response to ingested food allergen. 8, 9, 24 We therefore hypothesized that IgE-mediated mast cell activation might drive expansion of or activate cytokine production by intestinal ILC2 in murine models of food allergy.
We first interrogated the impact of allergen sensitization on ILC2
in the "intestinal anaphylaxis" model developed by Rothenberg and colleagues, which is both IgE and mast cell-dependent. 43 After intraperitoneal immunization with ovalbumin (OVA) adsorbed to alum and repeated intragastric OVA feedings, WT but not IgE-deficient mice developed robust serum levels of OVA-specific IgE (Figure 1A ). Enteral challenge with OVA provoked dramatic IgEmediated increases in the mast cell granule protease and mouse mast cell protease-1 (MMCP-1) in the serum of sensitized mice (Figure 1B) . Flow cytometric analysis of jejunal lamina propria leucocytes revealed a significant expansion of c-Kit + FceRIa + mast cells in WT but not IgE À/À mice ( Figure 1C ). We are aware that this finding contrast with previous reports using the same model with FceRIa We identified ILC2 on the basis of the absence of lineage (Lin) À markers combined with the presence of intracellular GATA-3 + (Figure S1 ). ILC2 also displayed a largely IgE-dependent expansion in food allergic mice ( Figure 1D ). We also consistently observed nonsignificant trends for ILC2 expansion in food allergic IgE À/À mice, suggesting additional mechanisms, such as a contribution from epithelial or tuft cells. Interestingly, intestinal ILC2 numbers were reduced at baseline in IgE À/À mice relative to WT controls (Figure 1D) . As ILC2 can promote mast cell growth and activation, lowered steady-state ILC2 numbers in IgE À/À mice may contribute to the lack of mast cell expansion in these mice.
While the intestinal anaphylaxis model provided evidence that
IgE was required for ILC2 expansion in food allergy, we reasoned that it would be important to corroborate the result using an approach in which sensitization could be achieved by the more physiologic route of ingestion. We therefore investigated the impact of peanut gavage on ILC2 homoeostasis in Il4raF709 mice, rendered inherently atopic by knock-in of an unconstrained form (lacking the ITIM motif) of the IL-4Ra chain. We previously reported that dramatic intestinal mast cell expansion and anaphylactic sensitivity to foods can be induced by repeated enteral exposure to allergen in the absence of adjuvant. 31 Following peanut feeding, allergy-prone ILC2 were unable to exacerbate IgE-mediated anaphylaxis to a statistically significant degree ( Figure 5B ). IL-13 has been shown to increase the response of vascular tissue to the mast cell mediators that cause anaphylaxis. 39 We investigated whether IL-13 from ILC2
would also exacerbate the shock resulting from administration of histamine or serotonin. Injection of activated WT ILC2 greatly magnified the loss of core body temperature in response to histamine (average D9C vs 4.5C) ( Figure 5C ). A similar effect was observed in response to serotonin ( Figure 5D ). These exacerbations were largely due to IL-13 produced by ILC2. Taken together, these observations demonstrate that ILC2 can amplify the intensity of IgE-mediated anaphylaxis by IL-13 induced increases in the sensitivity of target tissues to the mediators of hypersensitivity.
| DISCUSSION
The lack of consistent correlation between food-specific IgE levels in allergic patients and the severity of hypersensitivity reactions they exhibit when challenged strongly implicates the presence of IgE, and Lee et al found that ILC2 enhanced allergic symptoms in an IL-13-dependent manner. As our studies do not include experiments using mice with a lineage-specific disruption of IL-13 production in ILC2, we cannot conclude that ILC2-derived IL-13 is essential for the elicitation of anaphylaxis. However, our data support the conclusion that ILC2-derived IL-13 can enhance anaphylaxis driven by mast cells.
The target of ILC2-derived IL-13 appears to be the vascular tissue, which expresses receptors for IL-13. 50 The literature on allergic Statistical analysis by repeated measures 2-way ANOVA with Bonferroni post-tests at individual time-points. *P < .05, **P < .01, ***P < .001 and ****P < .0001. Data are representative of two independent experiments each asthma and atopic dermatitis also supports a predominantly tissuefocused impact of IL-13 from ILC2 on allergic pathology and suggests that additional IL-13 effects may be exerted on tissue remodelling and on intestinal permeability to macromolecules. 18, 51, 52 In this study, we examined one aspect of the interaction between mast cells and ILC2, focusing on the ability of mast cells to stimulate ILC2 expansion and activation. We unexpectedly found that the absence of IgE led to a reduction in intestinal ILC2 numbers, which is consistent with a role for IgE, and perhaps mast cells, in ILC2 homoeostasis. It remains to be seen whether FceRIa À/À mice also exhibit reduced ILC2 numbers. We have previously reported that the mast cell-ILC2 interaction operates in the opposite direction as well and that ILC2 can promote mast cell growth and degranulation. 24 Recent work in disparate areas of immunology has highlighted the two-way nature of the mast cell-ILC2 interactions, 25, 27, 53 with an essential role for mast cell activation in driving a host-protective ILC2 response in expulsion of gastrointestinal helminths. 54 Modest increases in intestinal ILC2 numbers have been reported previously in some models of food allergy, but frequently ILC2 secretion of IL-13 increases to a greater extent than total cell numbers. 24, 25, 49, 54, 55 At present, we suspect that inconsistent findings regarding ILC2 expansion likely relate to the lack of a standard approach for identifying these cells, but may also be due differences in the sites (lymph nodes or intestine) and timing (pre-or post-challenge) of analysis within the various food allergy models. It is plausible that ILC2, as innate cells, may reach peak frequency during the early stages of sensitization, before standard experimental end-points. The fact that we observed IgE-related differences in our model suggest that under certain conditions of allergen exposure, timing and analysis, there is an effect on the ILC2 response. Experimental animal studies have also illustrated roles for basophils in the pathology of food allergy, 11, 56, 57 and although interactions between basophils and ILC2
have not been addressed in these studies, basophil-derived IL-4 could theoretically also support ILC2 growth and activation.
This report defines a key link between innate cell types and the IgE-mediated adaptive response that drives anaphylaxis and describes a central mechanism that may alter the balance between non-reactive sensitization and lethal anaphylaxis. We suggest that reducing ILC2 activity, perhaps via IgE blockade, may be an effective means of limiting severe food reactions.
